Literature DB >> 33597159

Type-5 Bartter syndrome presenting with metabolic seizure in adulthood.

Aqeel Hussain1, Mahendra Atlani2, Abhishek Goyal3, Alkesh Kumar Khurana4.   

Abstract

Bartter syndrome is a very rare and heterogeneous disease with variable age of onset and symptom severity. Genotypically they have inherited disorders of the thick ascending limb in the renal tubular system, which manifest phenotypically as electrolyte imbalance due to loss of sodium, chloride and potassium. Gain of function mutations in the calcium-sensing receptor has been described in some patients with Bartter's syndrome (type-5 Bartter syndrome or autosomal dominant hypocalcaemia with Bartter syndrome) associated with hypocalcaemia and hypercalciuria differentiating it from Gitelman syndrome. This phenotype has been reported to present in adulthood with metabolic abnormalities. We present a case of a middle-aged woman who presented with metabolic seizures and on evaluation was found to have profound electrolyte abnormalities which were corrected with supplements and led to the resolution of symptoms. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  fluid electrolyte and acid-base disturbances; renal system

Mesh:

Year:  2021        PMID: 33597159      PMCID: PMC7893602          DOI: 10.1136/bcr-2020-235349

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

Review 1.  The genetics of kidney stone disease and nephrocalcinosis.

Authors:  Prince Singh; Peter C Harris; David J Sas; John C Lieske
Journal:  Nat Rev Nephrol       Date:  2021-12-14       Impact factor: 28.314

2.  Recurrent hypocalcemic tetany presenting to the emergency room: Answers.

Authors:  Vanshika Kakkar; Kaveri Pandit; Menka Yadav; Abhijeet Saha
Journal:  Pediatr Nephrol       Date:  2021-11-18       Impact factor: 3.714

Review 3.  Autosomal dominant hypocalcemia with a novel CASR mutation: a case study and literature review.

Authors:  Yingying Wu; Chao Zhang; Xiaojun Huang; Li Cao; Shihua Liu; Ping Zhong
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.